TIPRANAVIR - ORAL
Common Brand Name(s): Aptivus
Phonetic Pronunciation: (tie-PRAN-ah-veer)
Information last revised June 2010
What does TIPRANAVIR - ORAL look like?
Aptivus 250 mg Cap
Tipranavir must be used in combination with other medications to help control your HIV infection, thereby improving your ability to fight other infections and improving your quality of life. It also lowers your risk of getting complications of HIV disease (e.g., opportunistic infections, cancer). Tipranavir belongs to a class of drugs known as protease inhibitors. To be effective, tipranavir must be given with another protease inhibitor, ritonavir. Tipranavir is not a cure for HIV infection, and it does not prevent the spread of HIV to others through sexual contact or blood contamination (e.g., sharing dirty needles).
This is a summary and does NOT have all possible information about this product. This information does not assure that this product is safe, effective, or appropriate for you. This information is not individual medical advice and does not substitute for the advice of your health care professional. Always ask your health care professional for complete information about this product and your specific health needs.
The information contained in the First DataBank databases is intended to supplement the knowledge of physicians, pharmacists, and other healthcare professionals regarding drug therapy problems and patient counselling information. This information is advisory only and is not intended to replace sound clinical judgment in the delivery of healthcare services. First DataBank disclaims all warranties, whether expressed or implied, including any warranty as to the quality, accuracy, and suitability of this information for any purpose.
Copyright 2010 First DataBank, Inc.